Positive results for Exubera

摘要

Exubera,an inhaled rapid-acting insulin preparation,is as effective as subcutaneous insulin in achieving glycaemic control in patients with type 1 diabetes,new data show.In a study of 226 patients,improved glycaemic control was seen with both Exubera and subcutaneous insulin.After 12 weeks HbA_(1c) levels of patients using Exubera dropped from a baseline of 7.5 per cent to 7.1 per cent,compared with 7 per cent in the subcutaneous group.